Disable ads (and more) with a membership for a one time $4.99 payment
Which medication is not recommended in naive patients if HIV RNA >500,000, known HBV confection, or HIV genotypic testing not available?
Triumeq: Dolutegravir/abacavir/lamivudine
Dovato: Dolutegravir/lamivudine
Biktarvy: Bictegravir/Emtricitabine/TAF
Tivicay + Descovy: Dolutegravir + Emtricitabine/TAF
The correct answer is: Dovato: Dolutegravir/lamivudine
Based on the information provided, Dovato (dolutegravir/lamivudine) is not recommended in naive patients if they have high levels of HIV RNA (>500,000), known hepatitis B virus (HBV) infection, or if HIV genotypic testing is not available. This is because these factors may increase the risk of treatment failure with Dovato. The other options, Triumeq, Biktarvy, and Tivicay + Descovy, may be more suitable for these patients as they contain different combinations of antiretroviral drugs and may be better tolerated in specific patient populations. It is important to consult with a healthcare provider to determine the best treatment option for each individual patient, taking into consideration their medical history, viral load, and availability of HIV genotypic testing.